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Abstract
Basal cell carcinoma is the most common type of non-melanoma skin cancers, 
frequently observed in fair-skinned individuals. The major risk factors for develop-
ing basal cell carcinoma are environmental exposures, phenotypic and genetic 
traits, and immunosuppression. The diagnosis of basal cell carcinoma is based 
upon clinical examination and dermatoscopy findings and finally confirmed by 
histopathological analysis. There are five main clinicopathologic types of basal 
cell carcinoma, specifically, superficial, nodular, pigmented, morpheaform, and 
fibroepithelial variant. The dermatoscopic feature of all BCC is the absence of 
a pigment network. Dermatoscopy structures are further classified as vascular, 
pigment-related, and non-vascular/non-pigment-related structures. Vascular struc-
tures include arborizing vessels and short fine telangiectasias, while pigmented 
structures comprise maple leaf-like areas, spoke-wheel areas, multiple blue-gray 
globules, in-focus dots, and concentric structures. Additional structures such as 
ulcerations, multiple small erosions, multiple aggregated yellow-white globules, 
shiny white-red structureless areas, and white streaks are considered non-vascular/
non-pigmented structures. As treatment options highly depend on the type of BCC, 
dermatoscopy is of great value in management strategy, assessment of margins, and 
evaluation of response to non-ablative therapies.
Keywords: algorithms, dermatoscopy, disease management, carcinoma, basal cell, 
carcinoma, basal cell/diagnosis, skin neoplasms
1. Introduction
Basal cell carcinoma (BCC) is the most common type of non-melanoma skin 
cancers (NMSCs), most frequently observed in fair-skinned individuals. BCCs 
originate from the pluripotent cells of the bulge region of the hair shaft and the 
interfollicular epidermis. Even though BCCs rarely metastasize, they are locally 
invasive and destructive, and thus if not treated on time, present a therapeutic chal-
lenge. There are five main clinicopathologic types of BCC, specifically, superficial, 
nodular, pigmented, morpheaform, and fibroepithelial (also familiar as fibroepi-
thelioma of Pinkus) [1].
Regarding epidemiology, the incidence of BCC correlates well with geographic 
location, with the southern hemisphere and regions closer to the equator having 
higher incidence. The average amount of annual exposure to ultraviolet radiation 
(UVR) has insignificant correlation with the incidence of BCCs. Additionally, fair 
skin phototypes and increasing age are also well correlated with the incidence of 
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BCC [1, 2]. The median age for acquiring BCC is 68. However, the development 
of BCC is mostly related to skin color, with white populations being particularly 
prone to the development of BCC. Moreover, men have a higher risk for acquiring 
BCC than women, although the rise in BCC among younger women has been noted 
lately. According to the American Cancer Society, currently, the incidence of BCCs 
is on the rise by more than 10% per year in the United States. Similar increases in 
incidence have been observed worldwide over the last two decades [3, 4].
The risk factors for developing BCC are environmental exposures, phenotypic 
characteristics, genetic traits, and immunosuppression. UVR is the most significant 
risk factor, particularly intermittent intense episodes of UV exposure and sunburns 
early in life [4, 5]. Among phenotypic traits, fair skin pigmentation, light hair 
and eye color, and poor tanning ability are the most common risk factors for BCC 
[5]. Furthermore, indoor tanning usage, chronic immunosuppression, and to a 
certain degree long-term photochemotherapy (PUVA) as well as ionizing radiation 
influence the risk for BCC development [6–8]. Additionally, chronic immunosup-
pression may increase the risk for BCC [9]. Some inherited diseases such as nevoid 
basal cell carcinoma syndrome (NBCCS) or Gorlin-Goltz syndrome, xeroderma 
pigmentosum, Bazex-Dupré-Christol syndrome, Rombo syndrome, and oculocuta-
neous albinism (OCA) carry a great risk for developing BCC at an early age [10, 11]. 
Specific gene polymorphisms in regions responsible for pigmentary traits, such as 
melanocortin-1 receptor (MC1R), the human homolog of agouti-signaling protein 
(ASIP), and tyrosinase (TYR), are additionally associated with an increased risk for 
BCC [12].
Pathogenetically, UVR induces mutations in several tumor suppressor genes 
and proto-oncogenes that consequently lead to BCC formation [13, 14]. Mutations 
in genes causing hyperactivation of the hedgehog (HH) protein family pathway, 
including PTCH1 receptor, SMO signal transducer, and GLI transcription factors, 
are strongly associated with BCC development [15, 16]. Furthermore, the TP53 
tumor suppressor gene is also linked to BCC formation. The PTCH1 and TP53 
are considered UV signature mutations due to the strong association with UVR-
induced mutagenesis [13, 16].
Almost 70% of BCCs arise on the face and 15% on the trunk, while they rarely 
develop in the genital area [17]. The diagnosis of BCC is based upon clinical exami-
nation and dermatoscopy findings and finally confirmed by histopathological 
analysis. Since dermatoscopic features of BCC strongly assist the clinical diagnosis 
of BCC, clinicians must be familiar with typical dermatoscopic findings of various 
subtypes of BCC [17–19].
2. Dermatoscopy of basal cell carcinoma
Dermatoscopy or epiluminescence microscopy is a widely used tool that increases 
BCC detection accuracy and distinguishes BCC subtypes. Dermatoscopy features 
of BCC are classified into three main categories: vascular, pigment-related, and 
non-vascular/non-pigment-related. Vascular structures include arborizing vessels 
and short fine telangiectasias. Pigment-related structures consist of maple-leaf-like 
areas, spoke-wheel areas, multiple blue-gray globules (ovoid nests), in-focus dots 
(peppering/buckshot scatter), and concentric structures. Structures such as ulcer-
ations, multiple minor erosions, shiny white blotches and strands, red structureless 
areas, and multiple aggregated yellow-white globules are classified as non-vascular/
non-pigmented structures [20].
The most significant vascular dermatoscopic feature is arborizing vessels. More 
than three decades ago, arborizing vessels were described as the main feature 
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of BCC, with high diagnostic accuracy and predictive value of over 90% [21]. 
However, arborizing vessels are not limited to BCC but to any fast-growing lesions 
such as cysts and tumors, including benign skin tumors.
Various attempts to categorize dermatoscopic features for particular BCC 
subtypes have been described. Most of the studies focus on the vascular pattern in 
different forms of BCC. As mentioned before, besides the role in diagnosing BCC, 
dermatoscopy is of great value in management strategy, evaluation of response to 
non-ablative therapies, and margin detection before surgical excision. Regarding the 
management strategy of treatment, the first step is to distinguish between superficial 
and non-superficial BCC as it determines further management decision, with non-
surgical treatments considered the first-line option for sBCC, while surgical exci-
sion being the standard for nodular BCC (nBCC) and Mohs micrographic surgery 
representing optimal choice for more invasive infiltrative forms of BCC [22, 23]. 
Superficial BCC is characterized by an optimal response to non-ablative therapies, 
such as imiquimod and photodynamic therapy (PDT). The authors Urech et al. reveal 
that dermatoscopic findings of erosions or ulcerations strongly predict a favorable 
response to imiquimod [24]. The pigment-related structures can act as a competitive 
light-absorbing factor, significantly reducing the response rate of the tumor to PDT. 
This observation leads to the exclusion of PDT as a treatment option in the presence 
of pigmented features [25]. In monitoring the outcome of non-ablative therapeutic 
modalities, dermatoscopic disappearance of pigmented structures, ulceration, and 
arborizing telangiectasias are indicators of complete tumor clearance.
Further monitoring is recommended to recognize early post-treatment reap-
pearance of BCC-specific structures. However, the detection of white or red 
structureless areas and superficial fine telangiectasia does not provide explicit 
information on the possible presence of residual disease since these features might 
also appear as a result of treatment-induced skin atrophy [26].
In the non-superficial BCC, dermatoscopy is used in presurgical excision 
margins marking since it can detect a sub-clinical tumor expansion by revealing 
disease-related features in peripheral areas of clinically healthy skin.
3. Dermatoscopy of various BCC subtypes
3.1 Dermatoscopy of nodular basal cell carcinoma
Nodular BCC clinically manifests as a flesh-colored papule or nodule with a 
smooth surface typically located in the face region (Figure 1A–C). This subtype 
of BCCs is the most common and comprises approximately 60–80% of all cases of 
BCCs [1, 22, 27]. NBCCs usually have a pearly appearance and visible arborizing tel-
angiectasias, while their border is raised compared to the central part of the lesion. 
This elevated rolled border is one of the critical clues to diagnosis. Additional clinical 
feature of nodular BCC is ulceration, hence the terms “rodent ulcer” or “phagedenic 
ulcer” for describing the ulcerating forms of nBCC. In contrast to sBCC, which often 
emerges on the trunk, nBCCs usually arise in the head and neck area, especially on 
the cheeks, nose, nasolabial folds, forehead, and eyelids, although they may develop 
in any hair-bearing area of the skin [1, 2, 22, 28]. The clinical differential diagnosis 
of non-ulcerated nBCC lesions includes adnexal neoplasms, fibrous papules, intra-
dermal melanocytic nevi, amelanotic melanoma, sarcoidosis, cutaneous tubercu-
losis, and foreign body granulomas. Regarding ulcerating nBCC, squamous cell 
carcinoma (SCC) and keratoacanthomas are potential differential diagnoses [29].
NBCC is considered low-risk BCC; hence, standard surgical excision with 4-mm 
clinical margins with postoperative margin evaluation or electrodessication and 
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curettage (EDC) are the two available treatment options according to the National 
Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN 
Guidelines). EDC is an alternative therapeutic modality for patients who may not 
tolerate surgery or prefer this non-surgical treatment option [23].
Dermatoscopy findings of nBCC include arborizing vessels, large blue-gray 
ovoid nests, multiple blue-gray dots/globules, and ulcerations (Figure 1A–C). 
Figure 1. 
(A) Left: superficial BCC clinically presented as well-circumscribed red- to pink-colored patch. Right: 
superficial BCC with short fine telangiectasias (arrows), small brown-gray dots (circles), and white-red 
structureless areas. (B) Left: well-circumscribed slight scaly, pink-colored macule. Right: arborizing vessels 
with ramification (black arrows) and multiple yellowish structureless areas representing small ulcerations 
covered with crust (red arrows). (C) Left: clinical presentation of superficial pigmented BCC. Right: the more 
experienced dermatoscopist will recognize the leaf-like structures (red circles) and concentric structures (white 
circles), structures corresponding to dermo-epidermal pigmentation. (D) Left: BCC exhibiting the various 
amounts of pigment and scale. Right: the dermatoscopic features of superficial BCC are maple leaf-like areas 
(red circles) and shiny white, red structureless areas (stars) throughout the lesion. In contrast, blue-gray ovoid 
nests (square) point to the diagnosis of an infiltrative variant of BCC.
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Among the latter, classical arborizing vessels are the most distinguishable feature 
of nodular BCC (Figure 1A–C), easily identifiable as larger bright red stem vessels 
that branch into thinner branches [28]. Arborizing vessels correspond to dilated 
tumor vessels in the superficial dermis. Although the pigmentation features are 
the hallmark of pigmented BCC, they may be present in nodular BCC as well. 
The most common pigmentation feature of non-sBCC is blue-gray ovoid nests 
(Figure 1A and C). Blue-gray ovoid nests are pigmented structures that histo-
pathologically represent pigmented tumor nests invading the dermis. It is worth 
noting that nBCCs generally appear more pigmented in contrast to sBCCs. In 
nBCCs, blue-gray pigmentation usually arises in the center of the lesion, whereas 
maple leaf-like areas, spoke-wheel areas, and concentric structures are closer to 
the peripheral part of the lesion [30]. Ulcerations are structureless, red to black-
red areas in parts of epidermal loss (Figure 1A). In some cases, nBCC can even 
present with shiny white areas and rainbow patterns that occur when the polar-
ized light illuminates vascular structures of the tumor. Further dermatoscopic 
findings of nBCC include milia-like cysts and multiple aggregated yellow-white 
globules [31].
Histopathology of nBCC consists of large, round islands of basaloid keratino-
cytes that extend from the epidermis to the dermis. The nuclei form palisades at 
the periphery of the lesions, in addition to a lack of central nuclear organization. 
In some larger tumor islands, necrosis leads to the development of cystic spaces. As 
a result of ulceration, an adjacent inflammatory infiltrate develops. Additionally, 
mucin pools may form in cystic or nodulocystic BCCs [32, 33].
In conclusion, the most specific dermatoscopic features of nodular BCC are 
arborizing vessels together with ulcerations, while some nodular BCCs addition-
ally present with pigmented structures such as blue-gray ovoid nests. The surgery 
remains the cornerstone of the therapy of nBCC.
3.2 Dermatoscopy of superficial basal cell carcinoma
The superficial basal cell carcinoma clinically presents as well-circumscribed 
slightly scaly, shiny, red- to pink-colored non-firm macule, patch, or thin plaque 
(Figure 2A and B). The diameter of the tumor can range from a few millimeters 
to several centimeters. Additionally, the pigmented forms of sBCC may have a 
variable degree of spotty brown to black pigmentation (Figure 2C and D). Larger 
sBCC may also exhibit atrophic areas of hypopigmentation [1]. The central part of 
sBCC often appears atrophic in contrast to the pearly elevated border. The sBCC is 
locally destructive as it grows gradually and horizontally over time, reaching several 
centimeters in diameter if not treated. Induration, ulceration, and nodule all rarely 
appear as a result of the deeper invasion [2].
SBCC is the second most common subtype of BCC developing in approximately 
15% of all BCCs. The predilection sites for sBCCs are the trunk and extremities. 
Often multiple sBCC may occur in one individual [22]. It is important to distinguish 
sBCC from other BCCs because of the different treatment strategies available for 
this entity. Currently, depending on the individual clinical presentation, standard 
surgical excision with postoperative margin evaluation or electrodessication and 
curettage (EDC) are the treatments of choice for low-risk sBCC, while topical 
5-fluorouracil (5-FU) and 5% imiquimod are second-line treatment modalities 
[23, 34]. The differential diagnosis for sBCC includes actinic keratosis, Bowen’s 
disease, and solitary lichenoid keratosis, in addition to inflammatory diseases such 
as nummular eczema, psoriasis, and cutaneous lupus erythematosus. Regarding 
histopathology, sBCC is marked by foci of palisading basaloid cells connecting in a 
net-like pattern and extending to the papillary dermis [18, 29].
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The diagnosis of sBCC is based upon typical clinical features together with 
dermatoscopic findings and histopathological analysis. Dermatoscopy facilitates 
the differentiation of sBCC from other BCCs. The main dermatoscopic features 
of superficial BCC are maple-leaf-like areas, short fine superficial telangiecta-
sias, shiny white-red structureless areas, concentric structures, spoke-wheel 
areas, and multiple small erosions [29, 35]. However, among the latter, the most 
positive predictive patterns of sBCC are multiple small erosions and maple leaf-
like areas together with short fine superficial telangiectasias (Figure 2A and B). 
Under dermatoscopy, short fine telangiectasias appear as fine vascular structures 
with length up to 1 mm, and only a few branches or commonly, no branching  
at all [35].
Figure 2. 
(A) Left: nodular BCC clinically presented as a pink-colored nodule with a smooth surface. Right: 
dermatoscopy revealed small arborizing vessels (black arrows), blue-gray globules (circle), and scale due to 
ulceration (red arrow). (B) Left: nodular BCC may clinically manifest as a growing pink nodule. Right: the 
hallmark of nodular BCC is arborizing vessels. Be careful, vessels like this may blanch out if you press down 
hard on the lesion. (C) Left: skin-colored papule on the nose of the patient. Right: arborizing vessels identifiable 
as larger bright red stem vessels that branch into thinner branches (arrows) and gray-brown ovoid nests 
(square) are the most distinguishable features of nodular BCC.
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Recently dotted vessels have been described in sBCC located on lower extremi-
ties. As the dotted vessels are also a feature of Bowen disease, other features such 
as white shiny blotches/strands and superficial fine telangiectasia (SFT) should be 
considered when diagnosing sBCC in this anatomical region [36].
Furthermore, maple-leaf-like areas can be visualized as brown or gray/blue 
bulbous, leaf-like projections that never arise from the pigmented network or 
nearby confluent pigmented areas (Figure 2C and D). Histopathologically, they 
correspond to pigmented tumor islands that interconnect with lobular exten-
sions. Multiple small erosions are frequently seen in sBCC and they appear as 
small brown-red to yellow crusts (Figure 2B) covering the areas of epidermal 
loss [30, 37].
Another finding in sBCC is spoke-wheel areas that resemble radial arrays that 
join at the darker center. They are consistent with tumor nests arising and connect-
ing to the epidermis with finger-like projections and centrally located pigment. The 
areas of diffuse dermal and tumor fibrosis appear as opaque white to red-colored 
areas under dermatoscopy, and these are called white-red structureless areas, also 
familiar as milky-pink areas [38–40]. In addition, short white streaks also cor-
respond to dermal fibrosis and are more commonly seen in sBCCs. Recently, a new 
dermatoscopic feature of sBCC named negative maple leaf-like areas (NMLLA) has 
been described. NMLLA are round non-pigmented well-defined bulbous projec-
tions similar to maple leaf-like areas on the white-colored background. These areas 
represent non-pigmented tumor nests at the dermo-epidermal junction and are 
usually associated with sBCC in the trunk region [41].
Furthermore, loosely arranged, well-defined focused fine brown-to-gray dots 
can also represent an unspecific feature of sBCC. They correlate with pigment 
deposition at the dermo-epidermal junction or melanophages in the papillary 
dermis [42].
Finally, negative predictive patterns of sBCC are ulceration, blue-gray ovoid 
nests, and arborizing vessels. These findings are suggestive of non-sBCCs subtypes. 
Among the listed criteria, blue-gray ovoid nests strongly support the diagnosis of 
infiltrative non-sBCC, which is especially relevant in differentiating clinically flat 
pigmented lesions. The blue-gray color results from pigment deposition deeper in 
the dermis, whereas brown pigment corresponds to melanin accumulation at the 
dermo-epidermal junction [39].
Some authors also suggest clinical subdivision of sBCC to patch, patch-to-
plaque, and plaque forms, as more palpable forms of BCC often exhibit derma-
toscopic features of nodular BCC (nBCC) [43]. Another helpful finding, highly 
suggestive of sBCC is multiple small erosions in clinically flat lesions [44].
In brief, pigmented sBCC is defined by patterns corresponding to dermo-epider-
mal pigmentation, particularly maple leaf-like areas, spoke-wheel, and concentric 
structures, with the absence of blue-gray ovoid nests, arborizing vessels and 
ulceration [30]. By adhering to the latter, the diagnosis of sBCC can be made with 
the sensitivity of 81.9% and specificity of 81.8%. On the contrary, non-pigmented 
sBCC demonstrates superficial short fine telangiectasia, multiple small erosions, 
and translucent-to-opaque shiny white-red structureless areas. Dermatoscopy is 
a reliable method for distinguishing sBCC from other BCCs, and neoplastic and 
inflammatory disorders. Adding current dermatoscopy algorithms to clinical prac-
tice is of crucial importance for making the correct prebiopsy diagnosis [29, 35].
3.3 Dermatoscopy of pigmented BCC
Pigmented BCC is a variant of basal cell carcinoma that histologically 
exhibits increased melanin pigmentation. It is clinically presented as a nodular 
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pigmented lesion or pigmented macule (Figure 3A–E). However, around 30% 
of BCCs that are clinically classified as non-pigmented reveal pigmented fea-
tures under dermatoscopy; thus, the pigment-related structures may be found 
in all BCC subtypes, both superficially and non-superficially [30, 45]. Based 
Figure 3. 
(A) Left: BCC clinically presented as firm pigmented papule. Right: pigmented basal cell carcinoma with 
arborizing vessels (arrows) and blue-gray ovoid nests (squares). (B) Left: clinical presentation of pigmented 
BCC. Right: this pigmented BCC shows the so-called maple leaf-like features (red circles). (C) Left: nodular 
pigmented BCC clinically presented as firm pigmented papule. Right: the heavily pigmented BCC with large 
blue-gray blotches (squares), blue-gray ovoid nests, and globules (circle) and arborizing vessels at the periphery 
of the lesion (arrow). (D) Left: clinical examination revealed small pigmented papule. Right: dermatoscopic 
picture of classic BCC with spoken wheel structures at the periphery (white circles) and fine arborizing 
telangiectasia (black arrows) in the middle of the lesion. (E) Left: unusual localization of BCC at labia major. 
Right: atypical presentation of nodular pigmented BCC with large blue-gray areas, ulceration covered by 
crust (red arrow), and milia-like cysts (triangles). This nodular BCC is hardly distinguishable from nodular 
melanoma.
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on histopathology correlation, features representing pigment at the dermo-
epidermal junction, such as maple-leaf-like areas, spoke-wheel areas, concentric 
structures, and focus dots, are in brown and appear more frequently in the 
superficial and infiltrating variant of BCC (Figure 3B and D). In contrast, fea-
tures representing pigment in deeper layers of the dermis such as blue-gray ovoid 
nests and blue-gray globules are in blue or gray, and they are characteristic of the 
nodular subtype of BCC [37, 39, 45]. Multiple blue-gray globules are defined as 
numerous, loosely arranged round to oval, well-circumscribed structures similar 
but smaller than the ovoid nest (Figure 3A, C, and E). They histopathologically 
correlate with small tumor nests in the papillary or/and reticular dermis. On 
the other hand, large blue/gray ovoid nests are well-circumscribed, confluent, 
or near-confluent pigmented or elongated areas, more prominent than globules 
and not intimately connected to a pigmented tumor body (Figure 3A, C, and E). 
Regarding pathophysiology, they correspond to large tumor nests with pigment 
aggregates invading the dermis. Blue-gray blotches together with arborizing 
vessels represent pathognomonic findings of pigmented basal cell carcinoma. 
In-focus dot terms describe loosely arranged, well-defined small brown-gray 
dots, which appear sharply in focus. They correspond to small tumor aggregates 
in the superficial dermis or at the dermo-epidermal junction, although they may 
also represent free pigment deposits or melanophages at the junction. Maple leaf-
like areas are translucent brown-to-gray/blue peripheral bulbous extensions, 
mainly localized on the lesion's periphery that never arises from a pigmented 
network or adjacent confluent pigmented areas (Figure 3B). Histologically, 
they represent pigmented nests at the dermo-epidermal junction and in the 
superficial papillary dermis. Spoke-wheel areas are well-circumscribed radial 
projections, usually tan but sometimes blue or gray, meeting at an often darker 
(dark brown, black, or blue) central axis. They are a rare dermatoscopic feature, 
highly specific for BCC. Occasionally radial projections are not clearly defined, 
and they appear as globular structures with a darker center. In such cases, we 
call them concentric structures [37, 39, 45]. Heavily pigmented BCCs may show 
dermatoscopic features associated with melanocytic lesions, such as brown 
globules, a blue-white veil and peppering. It is not always possible to distinguish 
melanoma from BCC with dermatoscopy; therefore in that clinical setting, the 
correct management decision is more relevant than the diagnosis (Figure 3E).
3.4 Dermatoscopy of infiltrative BCC
Infiltrative BCC is an aggressive and recurrent BCC variant that constitutes 
5–10% of the BCCs. It is a histologic variant characterized by invasive growth 
patterns with clinically indistinct borders. This subtype of BCC is more aggres-
sive and requires wider surgical margins or Mohs surgery, in contrast to non-
infiltrative variants such as nodular or superficial BCC, which are commonly 
treated with standard surgical excision. The most common dermatoscopy features 
that point to infiltrating growth of BCC are arborizing vessels, fine telangiectasia, 
shiny white structureless areas, ulceration, and whitish background. Vessels 
found in the infiltrative variant of BCC are more delicate and more scattered, with 
fewer branches than nodular subtypes. A pigmented subtype of infiltrative BCC 
can exhibit blue-gray ovoid nests or multiple blue-gray in-focus dots [28, 37]. 
The novel dermatoscopic feature linked to the infiltrative form of BCC is called a 
circumferential stellate pattern. It is defined as a geometric star-shaped pattern 
extending outward from the circumferential peripheral edge of the tumor and 
identified by white lines, vessels, or uneven skin surface morphology [46].
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3.5 Dermatoscopy of morpheaform/sclerodermiform BCC
Morpheaform BCC is an uncommon variant of BCC in which tumor cells induce 
proliferation of fibroblasts within the dermis and an increased collagen deposition 
with sclerosis that clinically resembles a scar. The histologic extent often exceeds 
the clinical impression, leading to high recurrence rates after standard excision. 
Morheaform BCC displays dermatoscopic features at a later stage of development 
than other subtypes of BCCs [47]. Approximately 75% of tumors show a structure-
less hypopigmented porcelain area. Arborizing vessels are expected in morphea-
form BCC, and they tend to have less evident branching. This subtype of BCC is 
rarely pigmented, but when they are, dermoscopy shows blue-gray ovoid nests [36]. 
If pink-white areas and fine arborizing vessels are seen in high-risk zones such as 
the nose, cheek, and periauricular area, clinician should consider a diagnosis of 
sclerodermiforme BCC.
3.6 Dermatoscopy of fibroepithelial BCC
Another uncommon variant of BCC is fibroepithelial BCC. Fibroepithelial BCC, 
also known as Pinkus tumor, clinically appears as erythematous, flesh-colored 
dome-shaped papule or plaque. Differential diagnoses include benign skin lesions 
such as dermal nevus, fibroma, seborrheic keratosis, and even malignant tumors 
such as amelanotic melanoma [48]. Dermatoscopy patterns seen in fibroepithelioma 
of Pinkus are fine arborizing vessels that have less evident ramification and are 
smaller in caliber in contrast to telangiectasia seen in other forms of BCC accom-
panied by white streaks under polarized dermatoscopy that are called crystalline 
structures similar to those in other forms of BCC. Pigmented variants show brown-
gray structureless areas and blue-gray dots. Other common but unspecific findings 
are milia-like cysts and ulceration [48, 49].
3.7 Dermatoscopy of basosquamous carcinoma
Basosquamous carcinoma (BsC) is a controversial entity and has both diagnos-
tic and therapeutic challenges. BsC combines histopathologic and dermoscopic 
characteristics of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) 
[1]. Like SCC, BsC is more locally invasive and aggressive, and metastasizes more 
often than other forms of BCC. Dermatoscopy features comprise both features of 
BCC and SCC. Therefore, besides arborizing vessels, ulceration, and blood crust 
that are standard features of BCC, BsC is characterized by keratin masses, surface 
scaling, and white structureless areas, and dermoscopic features are mainly seen in 
SCC [27].
3.8 The dermatoscopic findings of other uncommon variants of BCC
The nevoid BCC that typically develops in Gorlin-Goltz patients together with 
palmar pits may show blue-gray dots, globules, or nests and arborizing vessels at the 
periphery.
Micronodular basal cell carcinoma is a histopathological term that applies to 
BCCs in which smaller aggregations of basaloid cells infiltrate the dermis. They have 
destructive behavior, with subclinical spread and high rates of recurrence. Only a 
few studies have specifically analyzed dermatoscopic features of micronodular BCCs. 
The main features were truncated vessels and multiple blue-gray globules [42].
BCCs with a linear appearance are sporadic, sometimes seen in association with 
different histological subtypes. The most frequently affected sites are the periorbital 
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area and the neck. The linear subtype of BCC may show any dermatoscopic features 
associated with BCC in general.
4. Conclusion
Generally observing, classic arborizing vessels are typically found in a nodular 
variant of BCC, while short fine telangiectasia points forward the superficial form 
of BCC. Structures associated with pigment could be roughly divided into two 
categories based on melanin deposition. All dermatoscopic subtypes of BCC can 
exhibit various amounts of pigment. Maple leaf-like areas, spoke-wheel areas, 
concentric structures, and in-focus dots indicate the presence of melanin at the 
dermo-epidermal junction and are a feature of superficial BCC. On the other hand, 
large blue-gray ovoid nests and multiple blue-gray dots and globules correspond 
to melanin at the dermal level. They are the characteristic of a non-superficial 
variant of BCC. Spoke-wheel areas are a rare dermatoscopic feature, but they are 
highly particular for BCC. Ulceration represents a loss of epidermis and portion of 
the dermis and is primarily seen in nodular lesions. Ulcerated areas are frequently 
covered with coagulated blood or crust, sometimes making it difficult for further 
dermatoscopic review. Multiple small erosions are the characteristic of a superficial 
variant of BCC, and they are smaller than ulcerations and clinically observed as a 
yellowish crust.
Diagnosis of BCC is not established on a single dermatoscopy feature, but rather 
on the coexistence of several dermatoscopic features together with clinical presen-
tation. Histopathology essentially yields the final and decisive diagnosis. Besides a 
prominent position in diagnosis, dermatoscopy holds an essential role in managing 
BCC, significantly improving the treatment and post-treatment outcome assess-
ment, possessing a beneficial role during all the stages of BCC management.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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